CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

743 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2024.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 622 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 51.5M shares .
Largest 10 shareholders include VANGUARD GROUP INC (6.1M shares), BlackRock, Inc. (4.24M shares), WELLINGTON MANAGEMENT GROUP LLP (3.74M shares), STATE STREET CORP (2.13M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.94M shares), Allspring Global Investments Holdings, LLC (1.76M shares), GEODE CAPITAL MANAGEMENT, LLC (1.22M shares), Meritage Group LP (1.19M shares), Clearbridge Investments, LLC (1.09M shares), and EMINENCE CAPITAL, LP (1M shares).
This table shows the top 622 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.